HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nicholas J Short Selected Research

Nucleophosmin

12/2020Nucleophosmin 1 Mutations in Acute Myeloid Leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nicholas J Short Research Topics

Disease

48Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2022 - 11/2015
38Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
09/2022 - 12/2016
32Philadelphia Chromosome
09/2022 - 12/2016
10Leukemia
11/2022 - 12/2017
9Neoplasms (Cancer)
12/2020 - 01/2014
7Myelodysplastic Syndromes (Myelodysplastic Syndrome)
05/2022 - 11/2015
7Residual Neoplasm
01/2020 - 01/2016
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2022 - 11/2017
4B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
12/2021 - 11/2015
4Infections
01/2020 - 01/2018
3Chromosome Aberrations (Chromosome Abnormalities)
01/2022 - 03/2017
3Thrombocytopenia (Thrombopenia)
01/2021 - 01/2016
3Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
01/2021 - 01/2017
3Pathologic Complete Response
07/2020 - 12/2018
2Hyperbilirubinemia
01/2022 - 11/2017
2Central Nervous System Diseases (CNS Diseases)
01/2022 - 10/2021
2Blast Crisis (Blast Phase)
01/2021 - 12/2017
2Cytopenia
01/2021 - 01/2020
2Disease Progression
01/2021 - 03/2018
2Hypertension (High Blood Pressure)
12/2020 - 12/2018
2Exanthema (Rash)
12/2018 - 11/2017
2Dehydration (Water Stress)
11/2008 - 06/2007
1Frailty
07/2022
1Hyperuricemia
01/2022
1Pneumonia (Pneumonitis)
01/2022
1Uterine Hemorrhage (Uterine Bleeding)
01/2021
1Juvenile Myelomonocytic Leukemia
01/2021
1Eosinophilia
01/2021
1Lymphoma (Lymphomas)
01/2021
1Neutropenia
01/2021
1Noonan Syndrome (Female Pseudo-Turner Syndrome)
01/2021
1Osteoporosis
12/2020
1Metabolic Bone Diseases (Osteopenia)
12/2020
1Sepsis (Septicemia)
07/2020
1Heart Arrest (Cardiac Arrest)
07/2020
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2020
1Myeloid Leukemia (Leukemia, Myelocytic)
01/2020
1Thymoma (Thymic Carcinoma)
06/2019
1Aplastic Anemia (Anemia, Hypoplastic)
06/2019
1Acquired amegakaryocytic thrombocytopenia
06/2019

Drug/Important Bio-Agent (IBA)

23venetoclaxIBA
11/2022 - 01/2020
17Tyrosine Kinase InhibitorsIBA
09/2022 - 01/2016
11DecitabineFDA Link
12/2021 - 01/2017
10blinatumomabIBA
09/2022 - 12/2017
9ponatinibIBA
05/2022 - 12/2016
7Vincristine (Oncovin)FDA LinkGeneric
10/2021 - 01/2016
6Cytarabine (Cytosar-U)FDA LinkGeneric
11/2022 - 01/2016
6Dasatinib (BMS 354825)FDA Link
05/2022 - 12/2016
6Inotuzumab OzogamicinIBA
01/2022 - 01/2018
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2021 - 11/2015
5Dexamethasone (Maxidex)FDA LinkGeneric
10/2021 - 01/2016
5Doxorubicin (Adriamycin)FDA LinkGeneric
10/2021 - 01/2016
4fms-Like Tyrosine Kinase 3IBA
01/2022 - 01/2019
4Azacitidine (5 Azacytidine)FDA Link
01/2022 - 01/2017
3Rituximab (Mabthera)FDA Link
10/2021 - 11/2015
3Transaminases (Aminotransferases)IBA
12/2018 - 11/2017
3fludarabineIBA
01/2018 - 11/2015
2AnthracyclinesIBA
05/2022 - 01/2016
2bcr-abl Fusion ProteinsIBA
01/2022 - 01/2020
2CreatinineIBA
01/2022 - 12/2018
2ofatumumabFDA Link
01/2021 - 07/2020
2ibrutinibIBA
01/2020 - 09/2018
2Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
01/2018 - 11/2017
2Clofarabine (Clolar)FDA Link
01/2018 - 11/2017
2Purine NucleosidesIBA
01/2018 - 11/2017
1CladribineFDA LinkGeneric
11/2022
1purineIBA
05/2022
1trametinibIBA
01/2022
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022
1Hydroxyurea (Hydrea)FDA LinkGeneric
01/2022
1enasidenibIBA
01/2022
1gilteritinibIBA
12/2021
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2021
1AzolesIBA
01/2021
1Core Binding Factors (Core-Binding Factor)IBA
01/2021
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
01/2021
1nelarabine (506U78)FDA Link
01/2021
1Luteinizing Hormone (Lutropin)FDA LinkGeneric
01/2021
1Lysine (L-Lysine)FDA Link
01/2021
1MethyltransferasesIBA
01/2021
1Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
01/2021
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2021
1Phosphotransferases (Kinase)IBA
01/2021
1Leuprolide (Lupron)FDA LinkGeneric
01/2021
1NucleophosminIBA
12/2020
1Nuclear Proteins (Protein, Nuclear)IBA
12/2020
1ruxolitinibIBA
01/2020
1Cell-Free Nucleic AcidsIBA
01/2020
1Gemtuzumab (Mylotarg)FDA Link
01/2020
1CR 6IBA
01/2020
1Imatinib Mesylate (Gleevec)FDA Link
01/2020
1Sorafenib (BAY 43-9006)FDA Link
01/2019

Therapy/Procedure

37Drug Therapy (Chemotherapy)
11/2022 - 01/2016
29Therapeutics
09/2022 - 11/2015
5Stem Cell Transplantation
07/2020 - 01/2016
4Induction Chemotherapy
01/2022 - 01/2016
3Salvage Therapy
01/2021 - 01/2020
2Immunotherapy
01/2022 - 01/2020
2Consolidation Chemotherapy
01/2020 - 01/2018
1Radiotherapy
01/2020